New groundbreaking NHS Treatment for primary progressive MS

May 9, 2019

It was announced by the National Institute for Health and Care Excellence (NICE) that ocrelizumab will be available for use on the NHS for early primary progressive MS, after previously being considered too expensive for its benefits. Following a petition launched by the MS Society, and signed by over 20,000 people, the decision has now been changed. The drug is the first to work at all against primary progressive MS as previously there were no drugs to treat people with primary progressive ms.

 

For more information click here

 

 

 

Please reload

Featured Posts

Seated Yoga - Temporarily suspended until September

July 6, 2019

1/4
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square
 

MULTIPLE SCLEROSIS SOCIETY. REGISTERED CHARITY NOS 1139257 / SC041990. REGISTERED AS A LIMITED COMPANY IN ENGLAND AND WALES 07451571

© 2018 BY MS SOCIETY NORTH DURHAM GROUP